Revisor Wealth Management LLC

Position in ABBV — AbbVie Inc.

CIK 1887409 AKRON, OH

Position in ABBV

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$855,324

+$121,513 QoQ

Shares Held

3,399

+0.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.36%

of 13F equity value

Holder Rank

#2,693

of 4,153 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Revisor Wealth Management LLC holds $7,877,632 across 8 Drug Manufacturers - General names. ABBV ranks #4 (10.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GSK	GSK plc	30,786	$1,613,802
2	JNJ	Johnson & Johnson	5,622	$1,427,819
3	AMGN	Amgen Inc	3,075	$1,113,519
4	ABBV	AbbVie Inc. This page	3,399	$855,324
5	LLY	ELI LILLY & Co	712	$853,994
6	MRK	Merck & Co., Inc.	5,906	$758,921
7	PFE	Pfizer Inc	30,193	$727,047
8	NVS	Novartis AG	3,364	$527,206

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$855,324	3,399	+0.7%	Shares	Sole	2026-07-22
2026-03-31	$733,811	3,374	+9.1%	Shares	Sole	2026-04-27
2025-12-31	$706,719	3,093	-8.5%	Shares	Sole	2026-01-27
2025-09-30	$782,836	3,381	-10.6%	Shares	Sole	2025-10-15
2025-06-30	$702,200	3,783	-3.2%	Shares	Sole	2025-07-15
2025-03-31	$819,013	3,909	+68.2%	Shares	Sole	2025-04-28
2024-12-31	$412,974	2,324	-43.6%	Shares	Sole	2025-02-20
2024-09-30	$813,815	4,121	-3.5%	Shares	Sole	2024-11-12
2024-06-30	$732,561	4,271	-39.2%	Shares	Sole	2024-08-12
2024-03-31	$1,279,980	7,029	+196.7%	Shares	Sole	2024-04-23
2023-12-31	$367,123	2,369	-31.7%	Shares	Sole	2024-01-10
2023-09-30	$517,387	3,471	+29.5%	Shares	Sole	2023-11-16
2023-06-30	$361,211	2,681	-2.0%	Shares	Sole	2023-11-21
2023-03-31	$436,195	2,737	—	Shares	Sole	2023-11-21
No filing history on record for this holder in this stock.